title: Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality.
authors.affiliation: Clinical Sciences Building, University of Nottingham, City Hospital, Nottingham NG5 1PB, UK.
authors.forename: Jo
authors.initials: J
authors.lastname: Leonardi-Bee
authors.affiliation: Clinical Sciences Building, University of Nottingham, City Hospital, Nottingham NG5 1PB, UK.
authors.forename: Sudhir
authors.initials: S
authors.lastname: Venkatesan
authors.affiliation: Clinical Sciences Building, University of Nottingham, City Hospital, Nottingham NG5 1PB, UK.
authors.forename: Stella G
authors.initials: SG
authors.lastname: Muthuri
authors.affiliation: Clinical Sciences Building, University of Nottingham, City Hospital, Nottingham NG5 1PB, UK. Electronic address: jvt@nottingham.ac.uk.
authors.forename: Jonathan S
authors.initials: JS
authors.lastname: Nguyen-Van-Tam
authors.affiliation: Clinical Sciences Building, University of Nottingham, City Hospital, Nottingham NG5 1PB, UK.
authors.forename: Puja R
authors.initials: PR
authors.lastname: Myles
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000188:drug therapy*; D008297:Male; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D053139:Oseltamivir / Q000627:therapeutic use*; D058873:Pandemics; D053243:Zanamivir / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir